Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency

NCT00004313 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Addison's Disease

Interventions

DRUG: dehydroepiandrosterone

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]